Rocatinlimab: "EASI-75 and vIGA-AD 0/1 Responses at Week 24"; Atopic dermatitis (Kyowa Hakko Kirin Pharma) - Jun 19, 2025 - Kyowa Kirin rocatinlimab Update: "Depth of skin response for patients treated with rocatinlimab vs PBO continued to increase through Week 24"
P3 data • Atopic Dermatitis • Immunology
|